1. Caio G, Volta U, Sapone A, et al. Celiac disease: a comprehensive currentreview. BMC Med 2019; 17: 142.
2. Leffler DA. and Schuppan D. Update on serologic testing in celiac disease.Am J Gastroenterol 2010; 105: 2520-4.
3. Orlando A, Linsalata M, Bianco G, et al. Lactobacillus rhamnosus GGProtects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy. Nutrients 2018; 10: 1698.
4. Martinello F, Roman CF, and Souza PA. Effects of probiotic intake onintestinal bifidobacteria of celiac patients. Arq Gastroenterol 2017; 54: 85-90.
5. De Angelis M, Rizzello CG, Fasano A, et al. VSL#3 probiotic preparationhas the capacity to hydrolyze gliadin polypeptides responsible for CeliacSprue. Biochim Biophys Acta 2006; 1762: 80-93.
6. Quagliariello A, Aloisio I, Bozzi Cionci N, et al. Effect of Bifidobacteriumbreve on the Intestinal Microbiota of Coeliac Children on a Gluten FreeDiet: A Pilot Study. Nutrients 2016; 8: 660.
7. Klemenak M, Dolinšek J, Langerholc T, Di Gioia D, Micetic-Turk D.Administration of Bifidobacterium breve Decreases the Production ofTNF-α in Children with Celiac Disease. Dig Dis Sci 2015; 60: 3386-92.
8. Sugai E, Nachman F, Váquez H, et al. Dynamics of celiac disease-specificserology after initiation of a gluten-free diet and use in the assessment ofcompliance with treatment. Dig Liver Dis 2010; 42: 352-8.
9. Jain R, Kumar P, Kapoor S, Basu S, Lomash A, Rohatgi S. Reliability ofcoeliac serology in monitoring dietary adherence in children with coeliacdisease on a gluten-free diet. Trop Doct 2019; 49: 192-6.
10. Fotoulaki M, Nousia-Arvanitakis S, Augoustidou-Savvopoulou P,Kanakoudi-Tsakalides F, Zaramboukas T, Vlachonikolis J. Clinicalapplication of immunological markers as monitoring tests in celiacdisease. Dig Dis Sci 1999; 44: 2133-8.
11. Håkansson Å, Andrén Aronsson C, Brundin C, Oscarsson E, Molin G,Agardh D. Effects of Lactobacillus plantarum and Lactobacillus paracaseion the Peripheral Immune Response in Children with Celiac DiseaseAutoimmunity: A Randomized, Double-Blind, Placebo-ControlledClinical Trial. Nutrients 2019; 11: 1925.
12. Smecuol E, Hwang HJ, Sugai E, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacteriuminfantis natren life start strain super strain in active celiac disease. J ClinGastroenterol 2013; 47 (2): 139-47.
13. Olivares M, Castillejo G, Varea V, Sanz Y. Double-blind, randomised,placebo-controlled intervention trial to evaluate the effects ofBifidobacterium longum CECT 7347 in children with newly diagnosedcoeliac disease. Br J Nutr 2014; 112: 30-40.
14. Deora V, Aylward N, Sokoro A, El-Matary W. Serum Vitamins andMinerals at Diagnosis and Follow-up in Children With Celiac Disease. JPediatr Gastroenterol Nutr 2017; 65: 185-9.
15. Valentini L, Pinto A, Bourdel-Marchasson I, et al., Impact of personalizeddiet and probiotic supplementation on inflammation, nutritionalparameters and intestinal microbiota-The "RISTOMED project":Randomized controlled trial in healthy older people. Clin Nutr 2015; 34(4): 593-602.
16. O'Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002; 97: 1463-7.
17. Francavilla R, Piccolo M, Francavilla A, et al. Clinical and MicrobiologicalEffect of a Multispecies Probiotic Supplementation in Celiac Patients WithPersistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial. J Clin Gastroenterol 2019; 53: 117-25.
18. Hong KS, Kang HW, Im JP, et al. Effect of probiotics on symptoms inkorean adults with irritable bowel syndrome. Gut Liver 2009; 3: 101-7.
19. Sinn DH, Song JH, Kim HJ, et al. Therapeutic effect of Lactobacillusacidophilus-SDC 2012 2013 in patients with irritable bowel syndrome.Dig Dis Sci 2008; 53: 2714-8.
20. Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulatesintestinal pain and induces opioid and cannabinoid receptors. Nat Med2007; 13: 35-7.
21. Kaukinen K, Lindfors K, Collin P, Koskinen O, Mäki M. Coeliac disease--a diagnostic and therapeutic challenge. Clin Chem Lab Med 2010; 48:1205-16.